Board of Directors

The CMPI Board of Directors is comprised of some of the nation’s leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future.

Gad Berdugo
General Partner,
Explorium Capital LLC

Fred Goodwin, M.D.
Professor of Psychiatry,
The George Washington University Medical Center.

Steven Sammut
Lecturer,
Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania

Michael Tew
Principal
SandHill RP

Mark Thornton, M.D., Ph.D.
Chairman and President,
Sarcoma Foundation of America

Michael Weber, M.D.
Professor of Medicine,
SUNY Downstate College of Medicine
Brooklyn, New York
Sign Up for Our Email Newsletter

RECENT NEWS

War on Vaping Threatens Public Health

War on Vaping Threatens Public Health

Will the government hamstring what is potentially the most important public health innovation of the 21st century?...  Read more

PBMs Are Hogging Our Drug Discounts

PBMs Are Hogging Our Drug Discounts

PBMs are knowingly profiting off the backs of American patients, pharmacists, and innovators....  Read more

Advancing 21st Century Pain Management Conference (August 17, 2018)

Advancing 21st Century Pain Management Conference (August 17, 2018)

CMPI conference: Advancing 21st Century Pain Management Keynote Speaker: FDA Commissioner Scott Gottlieb...  Read more

DRUGWONKS BLOG